Alaunos Therapeutics
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$398K N/A	$2.92M 634.17%	$5K -99.82%	Avg: $556.92M Low: $556.92M High: $556.92M avg. 11138420%	Avg: $87.52M Low: $87.52M High: $87.52M avg. -84.28%	Avg: $220.41M Low: $220.41M High: $220.41M avg. 151.81%
Net Income % change YoY	$-76.89M N/A	$-37.59M 51.10%	$-35.14M 6.53%	Avg: $-37.65M Low: $-2.07M High: $-2.07M avg. -7.14%	Avg: $-33.59M Low: $-33.59M High: $-33.59M avg. 10.78%	Avg: $-28.79M Low: $-28.79M High: $-28.79M avg. 14.28%
EBITDA % change YoY	$-76.06M N/A	$-34.70M 54.37%	$-30.90M 10.96%	Avg: $-111.38M Low: $-111.38M High: $-111.38M avg. -260.42%	Avg: $-17.50M Low: $-17.50M High: $-17.50M avg. 84.28%	Avg: $-44.08M Low: $-44.08M High: $-44.08M avg. -151.81%
EPS % change YoY	-$5.38 N/A	-$2.6 51.67%	-$21.97 -744.99%	Avg: -$0.13 Low: -$0.13 High: -$0.13 avg. 99.40%	Avg: -$2.1 Low: -$2.1 High: -$2.1 avg. -1515.38%	Avg: -$1.8 Low: -$1.8 High: -$1.8 avg. 14.28%
Operating Expenses % change YoY	$77.20M N/A	$38.16M -50.57%	$29.46M -22.77%	Avg: $229.06B Low: $229.06B High: $229.06B avg. 777224.19%	Avg: $36.00B Low: $36.00B High: $36.00B avg. -84.28%	Avg: $90.65B Low: $90.65B High: $90.65B avg. 151.81%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 5.97% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -2.07M, average is -37.65M and high is -2.07M.

Wall Street analysts forecast annual average revenue growth of 3712829.17% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $556.92M, average is $556.92M and high is $556.92M.

Wall Street analysts forecast annual average earnings growth of -467.23% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.13, average is -$0.13 and high is $-0.13.